… TO CEREBROVASCULAR DISEASE Atherosclerotic cerebrovascular disease accounts for
… Following focal brain ischemic events, a variety of therapies have been initiated, including …

… of dual antiplatelet therapy for patients with cerebrovascular diseases and therapeutic
dilemmas of … Although there have been no large-scale trials of long-term antiplatelet therapy for …

… and cerebrovascular disease, and the pathophysiological interactions between sleep
apnea and congestive heart failure. Our contributors were invited to review critically the current …

… have therapeutic implications. One exception might be in patients with symptoms and signs
suggestive of subclavian steal syndrome; arch aortography is indicated if the patient is fit and …

… cerebrovascular diseases. It contains nine sections: definitions, emergency assessment and
diagnosis, reperfusion therapy, antiplatelet therapy, … of ischaemic cerebrovascular disease, …

… diseases and disorders including cerebral vascular and neurological disorders. However, in
recent times, the ischemic cerebrovascular disease … for developed therapeutic to encounter …

… exert therapeutic benefits in stroke. Here, we discuss the current status of these BM-derived
stem cells in stroke therapy… When possible, we also discuss the relevance of this therapeutic …

… of anticoagulant therapy and surgical therapy has … ) cerebrovascular disease. Some difference
exists among the proponents of the various therapies as to the indications of each therapy …

… , neovascular insufficiency disease, and Alzheimer’s disease (AD). Furthermore, we
summarized the current therapeutic strategies targeting pericytes for cerebrovascular diseases. …

… Stroke is the second leading cause of death after ischemic heart disease and the third
leading cause of disability-adjusted life years lost worldwide. Cerebrovascular disease (CVD) is …